NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk
Jack P. Antel(Montreal Neurological Institute and Hospital), Felix Luessi, An Goris(University of Cambridge), Sergio E. Baranzini(University of California, San Francisco), Jonathan L. Haines(Vanderbilt University), Tone Berge(Oslo University Hospital), Steffan D. Bos(Oslo University Hospital), Bernhard Hemmer(Munich Cluster for Systems Neurology), Dana Horáková(Charles University), Jun‐ichi Kira(Fukuoka Hospital), Katrina Dedham(University of Cambridge), David R. Booth(Hammersmith Hospital), Maria Ban(University of Cambridge), Belinda J. Kaskow, Clive Hawkins(University of Liverpool), Pierre‐Antoine Gourraud, Ashley Beecham, Mariusz Butkiewicz, Elia Gil, Pierre Duquette(Centre Hospitalier de l’Université de Montréal), Shannon Warto, Hanne F. Harbo, Bertrand Fontaine(Institut du Cerveau), Christiane Graetz(Johannes Gutenberg University Mainz), Ingrid Kockum(Karolinska Institutet), Christiane Gasperi, Alastair Compston(University of Cambridge), Pavlína Kleinová(Charles University), Melissa Howard, Rogier Hintzen(Stanford University), Lisa F. Barcellos(University of California, San Francisco), Alexandra Gyllenberg, Elisabeth Gulowsen Celius(Oslo University Hospital), Luisa Bernardinelli(University of Pavia), Deanna Hribko, Roland Henry(University of California System), Ilijas Jelčić(University Hospital of Zurich), Manuel Comabella(Universitat Autònoma de Barcelona), Chris Cotsapas(Yale University), Bénédicte Dubois(University of California, San Francisco), Adrian J. Ivinson, Nadia Barizzone(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Phil De Jager(Washington University in St. Louis), Georgios M. Hadjigeorgiou, Stephen L. Hauser(University of California, San Francisco), Dorothea Buck, Christina M. Lill(University of Münster), Karolina Kucerova, David A. Hafler(Yale University)
Cited by 29
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
|Science|2005|2.4k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k